Tag Archives: patents

Supreme Court Remands In Myriad Appeal

Posted on March 26, 2012 by Warren Woessner

Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 1 Comment

“Handbook of Quality Procedures Before the EPO”

Posted on March 26, 2012 by Warren Woessner

The ECP, epi and Business Europe have collaborated to produce a downloadable, fifty page guide to practice before the EPO. While not binding on Examiners, it was issued under the authority of the EPO and is a sort of mini-MPEP, … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment

Indian Patent Office Grants Compulsory License To Bayer Drug

Posted on March 21, 2012 by Warren Woessner

Finding that Bayer had failed the requirement to “work” the invention in India, e.g., manufacture and sell at a reasonable price, the Indian Patent Office granted Natco Pharma, an Indian company, a “compulsory license” to make, use and sell  a … Continue reading →

Posted in Working Requirements | Tagged , , , , , , , , , , , , | 1 Comment

Supreme Court Reverses In Prometheus v. Mayo!

Posted on March 20, 2012 by Warren Woessner

In a decision dated March 20, 2012, Justice Breyer writing for a unanimous court, held that claims to administering a drug, followed by measuring the levels of metabolites of the drug, in order to optimize the amount administered, are not patent … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 8 Comments